The uptake and retrograde transport of noradrenaline (NA) within the axons of sympathetic neurons was investigated in an in vitro system. Dissociated neurons from the sympathetic ganglia of newborn rats were cultured for 3-6 wk in the absence of non-neuronal cells in a culture dish divided into three chambers. These allowed separate access to the axonal networks and to their cell bodies of origin. [3H]NA (0.5 X 10 -e M), added to the axon chambers, was taken up by the desmethylimipramine-and cocaine-sensitive neuronal amine uptake mechanisms, and a substantial part was rapidly transported retrogradely along the axons to the nerve cell bodies. This transport was blocked by vinblastine or colchicine. In contrast with the storage of [3H]NA in the axonal varicosities, which was totally prevented by reserpine (a drug that selectively inactivates the uptake of NA into adrenergic storage vesicles), the retrograde transport of [3H]NA was only slightly diminished by reserpine pretreatment. Electron microscopic localization of the NA analogue 5-hydroxydopamine (5-OHDA) indicated that mainly large dense-core vesicles (700-1,200-A diam) are the transport compartment involved. Whereas the majority of small and large vesicles lost their amine dense-core and were unable to take up 5-OHDA after reserpine pretreatment, the population of large dense-core vesicles and some small dense-core vesicles involved in the retrograde transport were resistant to this drug. It, therefore, seems that these vesicles maintained the amine uptake and storage mechanisms characteristic for adrenergic vesicles, but have lost the sensitivity of their amine carrier for reserpine. The retrograde transport of NA and 5-OHDA probably reflects the return of used synaptic vesicle membrane to the cell body in a form that is distinct from the membranous cisternae and prelysosomal structures involved in the retrograde axonal transport of extracellular tracers.
In general, neither the synthesis nor the degradation of macromolecular constituents of membranes in particular, occurs in the axons and nerve terminals of neurons (5, 16, 27, 28) . Efficient transport systems are therefore needed to carry newly synthesized material from the cell body to the nerve terminals and back to the cell body. These transport functions are served by fast and slow anterograde transport, and by retrograde transport, respectively (23, 47, 58) . Rapidly transported material in the anterograde direction is always present inside, or as a constituent of membranous organeUes, mostly vesicles or organdies morphologically resembling the smooth endoplasmic reticulum (sER; [17, 23, 50, 63] ). Organdies involved in the retrograde transport are tubular and vesicular structures, large cisternae, and prelysosomal organdies (multivesicular bodies, cup-shaped bodies; [46, 47, 50, 63] ). Although the direction of transport (anterograde or retrograde) for a given organeUe is certainly strictly regulated by the cell, the mechanisms responsible for the direction taken are unknown.
Membrane transport from the perikaryon to the nerve terminal serves two main functions: (a) renewal of the plasma membrane, involving the supply, e.g., of general structural constituents, and of specific receptors for extracellular signals, e.g., macromolecular factors, and neurotransmitters; and (b) renewal of synaptic vesicles (23, 28) . Biochemical evidence clearly indicates major compositional differences between synaptic vesicle membranes and plasma membranes (15, 34, 65, 68) . Although temporary fusions take place between the two types of membrane during exocytotic transmitter release, vesicle membrane seems to be retrieved selectively (25, 26, 38, 67) . Less clear is the origin of synaptic vesicles. Vesicles, especially large dense-core vesicles in adrenergic or serotoninergic neurons, are rapidly transported from the cell body to the terminals or varicosities (14, 21, 55, 59) , and it has been suggested that, after an initial exocytosis, their membranes contribute to the formation of small dense-core vesicles, the predominant type of vesicle in most adrenergic nerve endings (49) . However, in adrenergic neurons, budding of small and large catecholaminestoring vesicles from the axonal and terminal ER-like tubular network has aLso been observed (56) , and a catecholaminecontaining reticular network has been observed in axons and terminals (56, 61) . In neuromuscular junctions, synaptic vesicles can bud from larger membrane cisternae during recovery after massive stimulation (25) . It is not known whether the membrane components of synaptic vesicles and plasma membranes are part of the same organelle during anterograde transport, or whether they are always separated. The same is true for their retrograde transport. In adrenergic nerves, a retrograde transport of synaptic vesicle membrane is indicated by the accumulation of dopamine-fl-hydroxylase (an enzyme involved in the synthesis of NA and located in the membrane of synaptic vesicles; [34] ) and of NA not only proximal, but also distal to nerve constrictions (4, 14) .
Neuroanatomical tracing experiments in the central nervous sytem have shown, surprisingly, that some established and some putative neurotransmitters (glycine, gamma-aminobutyric acid [GABA], aspartate, glutamate, acetylcholine, dopamine, and serotonin) are selectively taken up by the respective nerve terminals and transported retrogradely to the cell bodies (1, 12) . For these small molecules to be transported over distances of several millimeters, a stable storage complex has to be formed. Besides the amines, only glycine has been shown to be associated with vesicles during anterograde transport, in Aplysia neurons (42) . The organelles involved in the retrograde transport of these transmitter molecules are not yet known.
Dissociated rat sympathetic neurons in a tissue culture dish divided into three chambers (7) were used to study retrograde axonal transport under well-defined conditions. Wc have shown that [3H]NA is taken up into the varicositics, and that part of it is transported retrogradcly in reserpine-resistant, mainly large, dense-core vesicles.
MATERIALS AND METHODS
Culture Procedure: Polystyrene fLux Scientific Inc., Newbnry Park, CA) or Aclar (Allied Chemical Corp., Morristown, N J) coverslips of 2S-ram diam were glued into 35-mm tissue culture dishes (Falcon Labware, Oxnard, CA) sterilized by ultraviolet irradiation, and coated with sterile collagen (calf skin, Sigma Chemical Co., St. Louis, MO). A Teflon ring separating the dish into a central chamber for the neuron cell bodies and two side chambers for axons ( Fig.  I a) was sealed onto the coverslip with silicon grease (Dow Coming high-vacuum grease; Dow Coming Corp., Midland, MI) as described by Campenot (7) .
Neurons were dissociated from superior cervical ganglia of newborn rats by a l-h incubation in 0A% trypsin (Sigma Chemical Co.) and 0.1% collagenase (Worthington Biochemical Corp., Freehold, N J) in Ca++/Mg++-free phosphatebuffered saline at 37°C, followed by I0 rain in 0.5% trypsin. After two washes, the ganglia were suspended in l ml of complete medium and triturated with a slliconized Pasteur pipette. 5,DOO-10,DO0 Neurons wcrc plated into the cell body chamber of each dish and cultured for 3-6 wk in a 5% CO2 in air atmosphere. The growth medium was an enriched LI~, COs-based medium as described by Mains and Patterson (39) , containing 50 ng/ml mouse nerve growth factor, prepared according to the modified method of Bocchini and Angcletti (54), 5% rat serum, 0.6 g/IDO ml Methocel (hydroxymethyl cellulose, Dow Chemical Co., Midland, MI), penicillin (1 DO U/nil), streptomycin (I DO/~g/ml; Sigma Chemical Co.), and l0 -s M cytosine arabinoside (Sigma Chemical Co.; [24] ).
Before the retrograde transport experiments, the density of the axonal networks in the axon chambers was checked, so that only cultures with comparable, high fiber densities were used. The axons were washed overnight in medium containing no Mcthocel, no cytosine arabinosidc, and 0.1% bovine scum albumin (BSA; Sigma Chemical Co.) instead of rat serum (LIs-BSA), to prevent complex effects of serum constituents. For this wash, the axon chambers wcrc filled with medium to the top, i.e., -3 mm above the fluid level of the cell body chamber, which enabled leaking cultures to be detected and discarded.
Retrograde Transport of [3 H] Noradrenaline: [aHINA (/-7,8-
[aH]noradrenaline, specific activity 32 or 37 Ci/mmol, Amersham Corp., Radiochemical Center, Amersham, England; or 44 Ci/mmol, New England Nuclear, Boston, MA) was diluted in Lls-BSA medium to a concentration of 0.7 × 10 -s M and added to the axons in 1DO ~l per axon chamber. Cultures were returned to the incubator for 6 h. At the end of the experiment, 20/.d of medium was taken from each axon chamber and 150 #1 from the slit containing the cell bodies for counting. All the remaining medium was then removed and the cell bodies were FIGURE 1 Chamber culture arrangement used in the present study (7) . (a) Teflon ring with left and right axonal chambers and central slit for the cell bodies. (b) Bottom of culture dish after removing the ring. Clumps of cell bodies in the center give rise to bundles of branching axons. Methylene blue stained, x 70, rinsed with 2 ml of L~5-BSA run through the slit-shaped cell body chamber. The cultures were air-dried, the Teflon ring was removed, and the coverslips were cot into left and right axon chambers, and cell body chamber, and the parts counted separately.
The amount of radioactivity in the medium of the cell body chambers at the end of the experiment indicated whether leakage occurred above the normal level (see below). Data obtained from such cultures were discarded. Due to the care that had to be taken in handling the axons and removing the previous medium from the axon chambers, the actual concentrations of [Ha]NA in the axon chambers, as determined for each culture at the end of the experiments, varied from 0.3 to 0.6 x 10 -6 M. Since the uptake of [3I-I]NA was linear between 0.3 and 0.6 x 10 -6 M, the counts obtained from axons and cell bodies were normalized to 0.5 x 10 -6 M for each cutture. Electron Microscopy: Axons were washed with L~r,-BSA as previously described, and incubated for 6 h with 5 x 10 -4 M 5-hydroxydopamine (5-OHDA; [5-OHDA • HBr]; Hoffmann-La Roche Inc., Basel, Switzerland) in Lr,-BSA. The incubation solution was renewed after 3 h. Control cultures were treated identically but incubated with L~.~-BSA alone. As a control for the specificity of the 5-OHDA uptake and labeling, DMI (7 x 10 -~ M) was present during the tracer incubation. Reserpine pretreatment of axons and cell bodies was carried out as described above. Before fixation, the axon chambers were rinsed once with Lt~-BSA.
Glutaraldehyde fixation (3% in 0.1 M phosphate buffer, pH 7.4) was performed for 1 h at room temperature, followed by extensive washes in 0.1 M phosphate buffer containing 5% sucrose, postfixation in I% OsO4, block staining in uranyl acetate, and embedding in Epon 812. The bichromate-osmium tetroxide fixation was made as described by Tranzer and Richards (62) : Briefly, cultures were treated on ice with ice-cold 1% glutaraldehyde, 0.4% formalin in a sodium chromate-potassium bichromate buffer, 0.1 M, pH 7.2 for 3 min, and then washed and stored overnight in 0.2 M sodium chromate-potassium bichromate buffer, pH 6.0, at 4°C. OsO4 (2%) impregnation was performed for 1 h at 4°C in chromate-dichromate buffer, 0.1 M, pH 7.2, followed by washes in acetate buffer. dehydration, and embedding in Epon 812.
Thin sections were cut from the axons or cell bodies parallel to the surface of the tissue culture dish and examined unstained or stained with uranyl acetate and lead citrate in a Zeiss EM 10 electron microscope.
RESULTS

Cultures
About 4 d after plating, the first axons penetrated the silicon grease barrier dividing the axon and cell body chambers. Within 2-3 wk, a dense network of fibers having many varicosities filled the axon chambers ( Fig. 1 b) 
. No non-neuronal cells (Schwann cells or fibroblasts) were present in the axon chambers. In the cell body chambers, the neurons had a strong tendency to aggregate into variously-sized clumps. Rarely, a non-neuronal cell on the plastic surface could be seen serving
as an attachment point for neurons or neuronal aggregates.
Uptake and Retrograde Transport of [ 3 H]Noradrenaline: Pharmacological Characterization
The addition of[aH]NA (0.5 x l0 -° M) to the axon chambers was followed by uptake into the axons and varicosities and the appearance of radioactivity in the cell body chamber (proximal axons and cell bodies) within 6 h (Fig. 2) . The uptake and transport of [3H]NA were blocked by the presence of a 400fold excess of unlabeled NA or by the disruption of microtu- bules by vinblastine or colchicine (Fig. 2) . In contrast with colchicine, which also blocked the storage or uptake of [3H]-[NA] in the varicosities and axons, vinblastine showed a selective effect on the retrograde transport. (The higher nonspecific values [i.e., in the presence of excess unlabeled NA] for the axon chambers result largely because rigorous washing was not possible: the axons detach easily and would be lost.) Retrograde transport and accumulation of radioactivity in the cell body chamber could already be seen 1-2 h after adding [3H]NA (data not shown). Because the minimal distance between the uptake sites and the cell bodies was 2-3 mm, a minimal transport rate of 2-3 mm/h can be estimated. The mean axonal length, however, was ~8-12 mm, and the true transport velocity may therefore well be higher.
Inhibition of the NA-degrading enzymes, monoamine oxidase (MAO) and, in one experiment, also COMT by tranylcypromine and U-0521, respectively, led to a small, barely significant increase in the amounts of [ZH]NA transported retrogradely ( Fig. 6 , MAO blockade). This result indicates that the transported radioactivity is [3H]NA rather than a product of its metabolism.
Between 0.1 and 1% of the total radioactivity added to the axons was found in the medium of the cell body chamber after 6 h of incubation. Whereas a small part of this radioactivity may represent [3H]NA or its metabolic products released from the cell bodies, the larger part originated from diffusion through the silicon grease seal. We showed that this leaked-[3H]NA did not contribute to the specific labeling of the nerve cell bodies by directly adding 0.5 x 10 -s M [3H]NA (the maximal concentration corresponding to that produced by leakage and release) to the chamber containing the nerve cell bodies. The radioactivity accumulated in the cell bodies after 6 h was <5% of the values achieved following retrograde transport.
Depolarization of the axons and varicosities by 54 mM K ÷ reproducibly led to a decrease in the amount of retrogradely transported [3H]NA, irrespective of whether the depolarization occurred 1 h before adding [3H]NA or continuously during the incubation with [3H]NA (Fig. 3 ). Wheat germ agglutinin (WGA), a lectin that binds to specific glycoproteins and glycolipids on the cell surface and that is taken up and transported in high amounts by these cells (M. Schwab and H. Thoenen, in preparation), seemed to slightly inhibit the retrograde accumulation of [aH]NA as well as the local accumulation in the axons (Fig. 3) .
Two possibilities existed for the mechanism of the specific uptake of [3H]NA by varicosities and axons as a prerequisite for retrograde transport: (a) binding of [aH]NA to presynaptic a-or B-receptors (51) followed by internalizing the ligandreceptor complex; and (b) uptake by the DMI-and cocainesensitive NA pump in the plasma membrane and transfer into the terminal cytoplasm, followed by pumping into the vesicular storage compartments (30) . Fig. 4 shows that neither yohimbine, a presynaptic a-blocker, nor L-propranolol, a blocker of B-receptors, abolished the retrograde transport of [3H]NA at concentrations that maximally block presynaptic adrenergic receptors (36, 51, 52) . In fact, propranolol at 10 -7 M enhanced the retrograde accumulation of [3H]NA. In contrast, DMI and cocaine, at the concentrations known to be effective from in vivo and in vitro experiments (29, 30, 44) , effectively blocked the uptake of [3H]NA into the axons and the retrograde accumulation of [aH]NA in the cell bodies ( Fig. 5 ). To our surprise, pretreatment of axons and cell bodies with reserpine (10 -~ M, a saturating dose [8, 53] ), a drug that selectively blocks the energy-dependent uptake of biogenic amines such as dopamine, noradrenaline, adrenaline, or serotonin from the cytoplasm into the vesicular storage compartments (8, 30, 31, 53) , did not block the retrograde transport of [3H]NA (Fig. 6 ). The decrease observed in some experiments varied from insignificant to a maximal value of 40%, but was never total. In the same cultures, the terminal and axonal storage of [3H]NA was completely abolished by reserpine ( Fig. 6 were also obtained with a higher concentration of reserpine (10 -~ M). Additional reserpine treatment of the neuronal cell bodies during the incubation with [3H]NA to inactivate all newly synthesized vesicles did not influence the retrograde transport either (data not shown). These results were not influenced by pretreatment with the MAO inhibitor, tranylcypromine. Increasing the concentration of [3H]NA in the axon chambers to 1.5 x 10 -~ M caused only a minor increase in the retrograde accumulation of [3H]NA in the nerve cell bodies, although the axonal labeling was greatly enhanced (Fig. 6 ). This result seems to indicate a saturation of the retrograde transport compartment, but, because the radioactivity present in the nerve cell bodies probably resulted from an equilibrium between the retrograde accumulation and subsequent metabolism or release, this interpretation has to be viewed with caution.
Electron Microscopic Observations
Nontreated glutaraldehyde-ftxed cultures showed the healthy appearance of the neurons under the present culture conditions. Most fibers in the axon chambers had many varicosities, showing bundles of microtubules and the total absence of ribosomes. Axosomatic and axodendritic typical asymmetric synapses were present in the cell body chambers. The bichromate-osmium tetroxide fixation for demonstrating catecholamines (62) revealed endogenous NA and/or dopamine as dense-cores mainly in small and large vesicles. In axons and cell bodies, small dense-core vesicles were less frequent, whereas in varicosities and synapses, most of the vesicles were small. In cultures older than 3 wk, varicosities and synapses feU into three groups according to the presence of dense-core vesicles: (a) terminals in which a majority of small vesicles had dense-cores; (b) the majority of terminals in which only some (5-20%) small vesicles had dense-cores; and (c) terminals with only clear vesicles. This observation, together with the biochemical demonstration of tyrosine hydroxylase activity as well as significant amounts of choline acetyltransferase in these cultures (R. Heumann, H. Gnalm, and M. Schwab, unpublished observations), indicate the presence of some largely adrenergic, some largely cholinergic, and a majority of dual-function neurons (35, 41) under the present culture conditions. Incubation of the axons with 5-OHDA (5 x 10 -4 M), a false transmitter that mimics the behavior of NA (but has a lower affinity for the amine uptake system) (60) for 6 h, resulted in the appearance of dense-cores in virtually all the small and large vesicles in the axonal varicosities in bichromate-osmiumfixed cultures (Fig. 7 a) . DMI abolished the 5-OHDA labeling, showing that it resulted exclusively from the specific uptake of 5-OHDA by the neuronal amine uptake mechanism, in spite of the high concentration of 5-OHDA used. (Glutaraldehyde fixation was not totally adequate for demonstrating all of these dense-cores. In most of the 5-OHDA experiments we therefore used bichromate-osmium tetroxide fixation, in spite of the poorer ultrastructural preservation.) Many neurons in longterm cultures in the presence of rat serum synthesized acetyl-SCHWAB AND "FHOENEN choline in addition to, or instead of catecholamines, but nevertheless retained the ability for uptake and vesicular storage of NA or 5-OHDA. These results confirmed the detailed descriptions of Landis (35) , Wakshull et al. (66) , and Reichardt and Patterson (43) . Tubular or reticulum-like structures containing 5-OHDA were occasionally seen, in both axons and varicosities. In the cell body chamber, the retrogradely transported 5-OHDA was reflected by an increase in the frequency of large dense-core vesicles mainly in the axons (Fig. 7 b) . However, the presence of endogenous catecholamines made a clear interpretation of this experimental condition difficult.
Because the biochemical experiments showed that the retrograde transport of NA is at the most influenced only slightly by reserpine, axons and cell bodies were pretreated with reserpine. This resulted in an almost total disappearance of the dark dense-cores characteristic of endogenous catecholamines in small and large vesicles (Fig. 8) . Some large vesicles containing pale dense-cores, probably of protein, glycoprotein, or peptide nature, could still be observed.
If 5-OHDA was added for 6 h to the axons of reserpinepretreated cultures, a very clear picture emerged: in the nonvaricose parts of the axons, irrespective of their localization in the cell body or axonal chamber, the majority of the labeled organdies were large dense-core vesicles of a diameter of 700-1200 A (Fig. 9a , Table I ). In addition, some small dense-core vesicles and elongated vesicles contained 5-OHDA, whereas none of the larger cisternae, sER-hke structures, or multivesicular or other prelysosomal bodies did. In the varicosities, some small vesicles contained dense-cores in addition to the labeled large vesicles (Fig. 9b ). Their number was, however, lower than expected from the total proportion of small versus large vesicles (Table I ). The number of labeled vesicles per varicosity was generally small but quite variable.
In the cell bodies the only labeled organelles found were large dense-core vesicles. Cell body labeling was relatively low altogether, suggesting a rapid transformation of the transport organdies (e.g., by fusion with lysosomal or Golgi compartments) leading to the loss of the transported storage complex visible by electron microscopy.
D I S C U S S I O N
Virtually all the agents so far shown to be transported by retrograde axonal transport have been macromolecular: material endogenous to the cell returning to the cell body from the axons and nerve terminals, or macromolecules taken up from the extracellular space (23, 47) . One of the few exceptions is found in the brain, where some established or putative neuro-transmitters (dopamine, serotonin, glycine, GABA, aspartate, glutamate, and acetylcholine) are accumulated by retrograde transport in the cell bodies of neurons using the corresponding, or a closely related molecule, as transmitter (1, 12). The reasons for this selectivity, and above all the compartments in which these low molecular weight substances are able to undergo retrograde axonal transport, remain unknown.
Using a chamber culture system that allowed separate access to the axons and cell bodies of dissociated sympathetic neurons in the absence of non-neuronal or target cells (7) , we have been able to characterize the uptake and retrograde axonal transport of [3H]NA and 5-OHDA with regard to their pharmacological and morphological properties. [3H]NA or 5-OHDA applied to the axons and varicosities was taken up by the DMI-and cocaine-sensitive amine carrier in the plasma membrane and transferred to two different intracellular storage compartments:
a reserpine-sensitive one that comprised the large majority of the small vesicles seen under the electron microscope in the varicosities, but that also contributed some large dense-core vesicles, and a reserpine-insensitive compartment. The latter was mainly responsible for the retrograde transport to the cell bodies. Electron microscopic localization of 5-OHDA revealed mostly large dense-core vesicles but also some small dense-core vesicles as this reserpine-resistant transport organelle. The retrograde transport velocity for [3H]NA is fast (minimally 2-3 mm/h) and the retrograde transport was totally abolished by the classical blockers of fast anterograde and retrograde transport, the microtubule-disrupting agents vinblastine and colchicine. These results exclude passive intra-axonal diffusion of the amines as a possible transport mechanism. Since blocking the NA-degrading enzymes did not significantly influence our results, the transported radioactivity probably represents intact [3HINA. Blockade of presynaptic a-and fl-receptors by yohimbine and L-propanolol, respectively (5 I), did not decrease the retrograde transport of [aH]NA, indicating that the internalization of [3H]NA after binding to a-or fl-receptors and subsequent receptor down-regulation is not how [3H]NA is taken up and transported (10, 22, 47) . Interestingly, the stimulation of NA release by 54 mM K ÷ decreased the accumulation of retrogradely transported [3H]NA, wherease 10 -7 M Lpropranolol increased the retrograde accumulation of [3H]NA. The stimulation of fl-receptors on adrenergic nerve terminals leads to an increase in the subsequent release of NA, and Lpropranolol, by blocking this positive feedback loop, has been shown to lead to a decrease of NA release (36, 51) . Whether the present results reflect the specific labeling of various intracellular pools of NA and how these pools are related to retrograde transport is unknown.
Reserpine-resistant compartments for NA have been observed repeatedly in pharmacological studies (3, 18, 20, 30, 57) . Because it was assumed that all storage vesicles are equal in their reserpine-sensitivity, these results were usually attributed to neuronal extravesicular binding sites. In the reserpinetreated perfused rabbit heart, this compartment was shown to be saturable and to take up NA with a higher affinity than the cocaine-sensitive pump in the plasma membrane (3). The present results clearly show that a reserpine-resistant compartment is responsible for the retrograde transport of [3H]NA and 5-OHDA, which is represented by a subpopulation of large vesicles (700-1200 A) that, upon loading with 5-OHDA, become dense-cored. In addition, a few small vesicles (300-600 ,~) in the varicosities (and rarely also in axons) are consistently resistant to reserpine pretreatment. These results confirm two earlier reports of reserpine-resistant retrograde transport of biogenic amines in the central nervous system (1, 64). Dopamine injected into the caudate nucleus of reserpine-treated rats accumulated rapidly in the dopaminergic cell bodies of the substrate nigra (64) , and the fast, colchicine-sensitive retrograde transport of [3H]serotonin from the olfactory bulb to the raphe nuclei was diminished by only 40% by reserpine pretreatment (1). In contrast, no retrograde accumulation of ['~H]serotonin was detectable after blockade of the neuronal uptake with fluoxetine, analogous to our results with DMI and cocaine in the adrenergic neurons (1).
The membrane of amine storage vesicles in adrenal medulla and adrenergic nerves is characterized by an energy-dependent carrier capable of transporting amines (e.g., dopamine, adrenaline, and serotonin) from the cytoplasm into the vesicles against a steep concentration gradient (30, (32) (33) (34) 68) . This amine carrier is inactivated by reserpine (8, 31, 53) . Because 1546 THE JOURNAL OE CELL BIOLOGY • VOLUME 96, 1983 reserpine is highly lipophilic, this inactivation is irreversible under physiological conditions (31) . In addition, there is an ATP carrier also driven by the proton gradient that is produced by a Mg~+-activated ATPase (68) . ATP, together with Ca ++, have an important function in forming the intravesicular storage complex for the amines (8, 34, 68) . These components are essential for an organelle able to store and transport [3H]NA or 5-OHDA. Dopamine fl-hydroxylase is another important component of adrenal medullary granules and at least the large vesicles from adrenergic nerves (33, 34, 68) . All these macromolecular constituents of synaptic vesicle membranes are synthesized in the cell bodies and supplied to the terminals by fast axonal transport (23) . In the case of adrenergic nerves, indications for their return to the cell body by retrograde transport came from two different observations: Early in the study of axonal transport accumulation of endogenous NA was seen not only proximal but also distal to nerve ligations (13) . Later it was demonstrated that dopamine-fl-hydroxylase also accumulates distal to ligations (4, 40) and that antibodies to dopamine-fl-hydroxylase are taken up selectively by adrenergic nerve terminals and transported by retrograde transport to the corresponding cell bodies (19, 48, 69) . Most interestingly, a large part of this retrogradely transported dopamine-fl-hydroxylase is enzymatically inactive, in contrast with the anterogradely transported enzyme in the same axons (40) . This indicates that local modifications of components of synaptic vesicles occur in the nerve terminals and may be a direct analogy to our finding of resistance to reserpine. Instead of assuming a vesicle type with amine transport characteristics totally different from the classical reserpine-sensitive ones, loss of reserpine sensitivity could be the result of a local modification of the vesicle membrane. Strong indications for such local modifications of axonal proteins in target regions were revealed by a two-dimensional gel electrophoresis analysis of fast-transported proteins in the rabbit optic system (45) . A protein (protein C, apparent mol wt 20,000) was found to shift its pI by 1 pH U in the lateral geniculate nucleus and by 2 pH U in the optic tectum as compared with its pI in the optic nerve. Such local modifications are attractive candidates for a signal for retrograde transport. What determines why a particular vesicle or organelle is transported anterogradely or retrogradely in an axon has remained enigmatic up to now.
In accordance with in vivo and in vitro observations (56, 61) we also found that large dense-core vesicles are not the only organelles in the axons containing catecholamines or capable of accumulating them. Small dense-core vesicles and elongated and tubular structures are also present, although in the varicosities small vesicles clearly represent the most common amine storage compartments (90% in our cultured cells). Formation of vesicles by budding from reticular or tubular structures, or formation of small vesicles from the membrane of large densecore vesicles has been suggested mainly on the basis of electron microscopic observations (49, 56, 61) . In the case of the large dense-core vesicles engaged in retrograde transport shown in this study, their origin in the nerve terminals could not be decided.
Extracellular macromolecules taken up by nerve terminals are transported retrogradely in large cisternae, tubular structures, or cup-shaped or multivesicular prelysosomal bodies (2, 6, 11, 23, 37, 46, 47, 63) . This has been observed in many in vivo and in vitro situations, and is also true for sympathetic neurons growing in chamber cultures (9; [M. Schwab and H. Thoenen, in preparation] ). These compartments are clearly different from the vesicles transporting NA or 5-OHDA, re-
